Hantech Bio-Technology Co (ROCO:1294) Stock Based Compensation: NT$0.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1294 Hantech Bio-Technology Co Ltd ROCO:1294
74 GF Score
Price NT$56.10
GF Value NT$80.55
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hantech Bio-Technology Co Stock Based Compensation?

Hantech Bio-Technology Co ROCO:1294 -3.11% 74 Stock Based Compensation is NT$0.1 Mil as of Mar. 2026. GuruFocus rates ROCO:1294 with a GF Score™ of 74/100 and a GF Value™ of NT$80.55 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Hantech Bio-Technology Co's Stock Based Compensation for the three months ended in Mar. 2026 was NT$0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.1 Mil.

Hantech Bio-Technology Co Stock Based Compensation Related Terms

Hantech Bio-Technology Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Hantech Bio-Technology Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hantech Bio-Technology Co Stock Based Compensation Chart

Hantech Bio-Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 4.22 0.17 0.05 1.03 0.11

Hantech Bio-Technology Co Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.02 0.03 0.02 0.02
ROCO:1294
74GF Score
Hantech Bio-Technology Co Ltd ROCO:1294
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hantech Bio-Technology Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.1 Mil.

What does a Stock Based Compensation of NT$0.1 Mil mean?
Hantech Bio-Technology Co (ROCO:1294) has a Stock Based Compensation of NT$0.1 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hantech Bio-Technology Co and its competitors.
Is Hantech Bio-Technology Co's Stock Based Compensation too high?
Hantech Bio-Technology Co's current Stock Based Compensation is NT$0.1 Mil. Overall, Hantech Bio-Technology Co has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's Stock Based Compensation compare to KHC and GIS?
Hantech Bio-Technology Co's Stock Based Compensation of NT$0.1 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Consumer Packaged Goods company?
A good Stock Based Compensation depends on the Consumer Packaged Goods industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Hantech Bio-Technology Co and its competitors. Hantech Bio-Technology Co's current Stock Based Compensation is NT$0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$80.55, compared to a current price of NT$56.10 — trading 30.4% below its estimated fair value. The current Stock Based Compensation is NT$0.1 Mil. Hantech Bio-Technology Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current Stock Based Compensation is NT$0.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?

Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued. The current stock price of NT$56.10 is trading 30.4% below its estimated GF Value™ of NT$80.55. GuruFocus considers Hantech Bio-Technology Co to be Significantly Undervalued.

Key valuation signals for ROCO:1294:

  • Stock Based Compensation: NT$0.1 Mil
  • GF Value™: NT$80.55 vs. price of NT$56.10 (30.4% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hantech Bio-Technology Co Business Description

Address No. 101, Gongye Road, Xihu Township, Changhua, TWN, 514
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
74GF Score

Get the complete analysis for ROCO:1294

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$56.10
Price
NT$80.55
GF Value